Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Megan, Shelby"'
Autor:
Susannah Holmes, Henry J. Kirkwood, Richard Bean, Klaus Giewekemeyer, Andrew V. Martin, Marjan Hadian-Jazi, Max O. Wiedorn, Dominik Oberthür, Hugh Marman, Luigi Adriano, Nasser Al-Qudami, Saša Bajt, Imrich Barák, Sadia Bari, Johan Bielecki, Sandor Brockhauser, Mathew A. Coleman, Francisco Cruz-Mazo, Cyril Danilevski, Katerina Dörner, Alfonso M. Gañán-Calvo, Rita Graceffa, Hans Fanghor, Michael Heymann, Matthias Frank, Alexander Kaukher, Yoonhee Kim, Bostjan Kobe, Juraj Knoška, Torsten Laurus, Romain Letrun, Luis Maia, Marc Messerschmidt, Markus Metz, Thomas Michelat, Grant Mills, Serguei Molodtsov, Diana C. F. Monteiro, Andrew J. Morgan, Astrid Münnich, Gisel E. Peña Murillo, Gianpietro Previtali, Adam Round, Tokushi Sato, Robin Schubert, Joachim Schulz, Megan Shelby, Carolin Seuring, Jonas A. Sellberg, Marcin Sikorski, Alessandro Silenzi, Stephan Stern, Jola Sztuk-Dambietz, Janusz Szuba, Martin Trebbin, Patrick Vagovic, Thomas Ve, Britta Weinhausen, Krzysztof Wrona, Paul Lourdu Xavier, Chen Xu, Oleksandr Yefanov, Keith A. Nugent, Henry N. Chapman, Adrian P. Mancuso, Anton Barty, Brian Abbey, Connie Darmanin
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-13 (2022)
Free-electron lasers are capable of high repetition rates and it is assumed that protein crystals often do not survive the first X-ray pulse. Here the authors address these issues with a demonstration of multi-hit serial crystallography in which mult
Externí odkaz:
https://doaj.org/article/2126addb96a243bbab803f29ff675139
Autor:
Ryan C. Lynch, Stefan Alig, Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman, Andrei Shustov, Brian Till, Vikram M. Raghunathan, Yolanda Tseng, Hilary Coye, Megan Shelby, Susan Ottemiller, Sarith Keo, Kaitlin Verni, Hongyan Du, Jackie Vandermeer, Ashley Gaston, Heather Rasmussen, Avanti Gulhane, Delphine L. Chen, Paul Martin, Edmond Marzbani, Jenna Voutsinas, Ash A. Alizadeh, Ajay K. Gopal
Publikováno v:
HemaSphere, Vol 6, Pp 26-27 (2022)
Externí odkaz:
https://doaj.org/article/1dca62dfced740de83e0d17bd541a259
Autor:
Kyoung E. Kweon, Joel Varley, Tadashi Ogitsu, Liwen F. Wan, Megan Shelby, Zhaoning Song, Randall J. Ellingson, Yanfa Yan, Jonathan R. I. Lee
Publikováno v:
Chemistry of Materials. 35:2321-2329
Autor:
Matthew J. Laurence, Timothy S. Carpenter, Ted A. Laurence, Matthew A. Coleman, Megan Shelby, Chao Liu
Publikováno v:
Membranes, Vol 12, Iss 4, p 392 (2022)
Proteins embedded in biological membranes perform essential functions in all organisms, serving as receptors, transporters, channels, cell adhesion molecules, and other supporting cellular roles. These membrane proteins comprise ~30% of all human pro
Externí odkaz:
https://doaj.org/article/93692e602f784c0f8fd397bbc06b54d2
Autor:
Ryan C. Lynch, Stefan K. Alig, Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman, Andrei Shustov, Brian G. Till, Vikram Raghunathan, Yolanda D. Tseng, Hilary Coye, Megan Shelby, Susan Ottemiller, Sarith Keo, Kaitlin Verni, Hongyan Du, Jacquelin Vandermeer, Ashley Gaston, Heather A. Rasmussen, Avanti Gulhane, Delphine Chen, Eric Wayne Dean, Paul S. Martin, Edmond A Marzbani, Jenna M. Voutsinas, Ash A. Alizadeh, Ajay K. Gopal
Publikováno v:
Blood. 140:6547-6549
Autor:
Ryan C Lynch, Chaitra S Ujjani, Christina Poh, Edus H Warren, Stephen D Smith, Mazyar Shadman, Brian G. Till, Vikram Raghunathan, Stefan Alig, Ash A Alizadeh, Avanti Gulhane, Delphine Chen, Yolanda Tseng, Hilary Coye, Megan Shelby, Susan Ottemiller, Sarith Keo, Kaitlin Verni, Hongyan Du, Jacquelin Vandermeer, Ashley Gaston, Heather Rasmussen, Paul Martin, Edmond Marzbani, Jenna M Voutsinas, Ajay K Gopal
Publikováno v:
Blood.
Concurrent administration pembrolizumab with chemotherapy in untreated classical Hodgkin lymphoma (CHL) has not previously been studied. To investigate this combination, we conducted a single arm study of concurrent pembrolizumab with AVD (APVD) for
Autor:
Ryan C, Lynch, Christina, Poh, Chaitra S, Ujjani, Edus H, Warren, Stephen D, Smith, Mazyar, Shadman, Karolyn, Morris, Sydney, Lee, Heather, Rasmussen, Susan, Ottemiller, Megan, Shelby, Sarith, Keo, Kaitlin, Verni, David M, Kurtz, Ash A, Alizadeh, Jacob J, Chabon, Gregory J, Hogan, Andre, Schulz, Theodore A, Gooley, Jenna M, Voutsinas, Ajay K, Gopal
Publikováno v:
Blood advances.
The POLARIX trial demonstrated the superiority of polatuzumab vedotin (Pola) over vincristine in the R-CHOP regimen for large B-cell lymphomas, but it is unknown if Pola can be safely incorporated into intensified regimens (eg. DA-EPOCH-R) typically
Autor:
Ryan C Lynch, Christina Poh, Chaitra Shankar Ujjani, Edus H. Warren, Stephen Douglas Smith, Mazyar Shadman, Karolyn Morris, Heather Rasmussen, Susan Ottemiller, Megan Shelby, Sarith Keo, Jake J. Chabon, Ted Gooley, Jenna M. Voutsinas, Ajay K. Gopal
Publikováno v:
Journal of Clinical Oncology. 40:7546-7546
7546 Background: The phase 3 POLARIX trial demonstrated the superiority of polatuzumab vedotin (Pola) over vincristine in the R-CHOP regimen for large B-cell lymphomas. However, it is unknown if Pola can be safely incorporated into intensified regime
Autor:
Mazyar Shadman, Edus H. Warren, Chaitra S. Ujjani, Ash A. Alizadeh, Brian G. Till, Heather A. Rasmussen, Ajay K. Gopal, Avanti Gulhane, Stefan Alig, Paul S. Martin, Hilary Coye, Edmond Marzbani, Ryan C. Lynch, Megan Shelby, Jacquelin Vandermeer, Christina Poh, Delphine L. Chen, Andrei R. Shustov, Jenna M. Voutsinas, Yolanda D. Tseng, Stephen D. Smith, Hongyan Du, Susan Ottemiller, Jason Lukas, Eric Wayne Dean
Publikováno v:
Blood. 138:233-233
Introduction ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) represents standard frontline therapy for classical Hodgkin lymphoma (CHL) in North America. Substituting brentuximab vedotin for bleomycin in this regimen demonstrated improved
Autor:
Nicole Swanson, Hilary Coye, Eunice Shim, Michael D. Johnson, Katie Blue, Megan Shelby, Sabrina Kdiry, Catherine Broome, Chaitra S. Ujjani, Hongkun Wang, Ryan C. Lynch, Siyu Wang, David G. Maloney, Catherine Lai, Brian G. Till, Ming Tan, Lori A. Leslie, Mazyar Shadman, Ajay K. Gopal, Stephen D. Smith, Bruce D. Cheson, Pari Ramzi, Edus H. Warren, Yolanda D. Tseng, Andrei R. Shustov
Publikováno v:
Blood. 136:46-47
Background: Ibrutinib (I) and venetoclax (V) have each demonstrated modest single-agent activity in relapsed/refractory follicular lymphoma (FL) (Gopal A, JCO 2018; Davids M, JCO 2017). Preclinical data have shown synergy with these agents in B-cell